Sentences with phrase «against pharmaceutical marketing»

Not exact matches

State Attorney General Andy Beshear is bringing suit against Endo Pharmaceuticals, which makes the opioid Opana ER, for alleged fraudulent and deceptive marketing practices which have contributed to a rising tide of painkiller - related deaths in Kentucky.

Amgen's 22 % ROIC is among the best in the large - cap pharmaceutical industry, and it's undervalued against both its peers and the broader market.

Alcohol Industry Bankrolls Fight Against Legal Pot in Battle of the Buzz: The fight against legalized pot is being heavily bankrolled by alcohol and pharmaceutical companies, terrified that they might lose market sAgainst Legal Pot in Battle of the Buzz: The fight against legalized pot is being heavily bankrolled by alcohol and pharmaceutical companies, terrified that they might lose market sagainst legalized pot is being heavily bankrolled by alcohol and pharmaceutical companies, terrified that they might lose market share...

The lawsuit takes primary aim against pharmaceutical companies that make promote, market and distribute opioid - based drugs such as OxyContin and Percocet and generics such as oxycodone and hydrocodone.

Shimsky, a Hastings - on - Hudson Democrat who first introduced the plan on June 19, told the Review the legislation would be directed against a number of pharmaceutical companies that have used deceptive marketing of opioid painkillers, seeking punitive and compensatory damages for the costs already expended by Westchester County.

In late April, a company called Hi - Tech Pharmaceuticals filed a $ 200 million claim for damages against Cohen and two colleagues, after the researchers published a paper suggesting Hi - Tech and other companies were marketing supplements that contained an amphetaminelike stimulant, BMPEA, which they mislabeled as Acacia rigidula, a shrub that grows in Texas and south into Mexico.

Among the interesting topics covered in Pathways are: the changing role of the patient in the total health equation and the ways in which decentralized information is affecting their expectations and demands; the dearth of pipeline products among international pharmaceutical companies against a backdrop of increased research and development spending; the dynamics of emerging markets and their rising demand for therapies in chronic disease; the value of drugs and biotechnology solutions within the context of global economic realities.

Professor Hayday added: «This is very significant because antibodies make up one of the largest sectors of the pharmaceutical market, and one of the great quests in the pharmaceutical industry is to be able to routinely generate antibodies against human proteins implicated in diseases.

The pharmaceutical and healthcare industries use front groups disguised as «patients rights» advocates to market their products and to lobby against government policies that might affect their profits.

A product liability case against a pharmaceutical or medical device manufacturer may be appropriate if the manufacturer failed to warn the public about inherent dangers in a drug, hid information about serious drug implications from the FDA, failed to follow marketing protocol, or allowed a product to be introduced to the market when the manufacturer knew or should have known of the product's potential danger.

Wrongful death cases are common against large pharmaceuticals companies for producing and marketing unsafe drugs or for not fully disclosing all of the potentially dangerous side effects of a particular drug.

Career highlights include defending a director prosecuted in the largest direct tax prosecution ever conducted by CPS Revenue & Customs Division; advising a range of individuals involved in the US / UK investigations into the alleged manipulation of the foreign exchange market and the LIBOR / EURIBOR rate; pursuing an appeal against a sentence to the European Court of Human Rights; and conducting an internal investigation on behalf of a pharmaceutical company.

Meantime, more people are coming forward to file their Actos lawsuits against drug maker Takeda Pharmaceuticals, its subsidiaries, and Eli Lilly, which has been active in marketing the diabetes drug in the US.

NPR also successfully represented the States of Alaska, Montana, and Utah in litigation against pharmaceutical manufacturers involving false marketing and labeling of antipsychotic drugs.